Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹117 Cr
Revenue (TTM)
₹132 Cr
Net Profit (TTM)
₹10 Cr
ROE
24.1 %
ROCE
25.2 %
P/E Ratio
16.4
P/B Ratio
1.9
Industry P/E
39.17
EV/EBITDA
8.2
Div. Yield
0 %
Debt to Equity
0.4
Book Value
₹36.3
EPS
₹5.6
Face value
10
Shares outstanding
17,148,800
CFO
₹--
EBITDA
₹--
Net Profit
₹--
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Zenith Drugs
| -15.8 | -9.5 | 20.6 | 7.9 | -- | -- | -- |
|
BSE Healthcare
| -4.7 | 1.2 | 2.2 | 17.0 | 26.5 | 21.0 | 10.2 |
|
BSE Small Cap
| -4.1 | 2.5 | 11.1 | 1.2 | 30.1 | 33.4 | 16.8 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Zenith Drugs
|
68.0 | 117.1 | 131.6 | 9.7 | -- | 24.1 | 16.4 | 1.9 |
| 434.7 | 3,961.1 | 2,387.0 | 168.1 | 9.7 | 12.7 | 23.6 | 2.9 | |
| 993.5 | 12,168.5 | 2,386.9 | 485.6 | 26.1 | 18.1 | 25.1 | 4.3 | |
| 316.1 | 3,452.6 | 150.8 | 48.8 | 42.1 | 20.7 | 70.8 | 13.9 | |
| 277.7 | 2,568.6 | 1,664.9 | -77.9 | -0.9 | -7.1 | -- | 2.5 | |
| 61.9 | 3,380.3 | 1,811.6 | 118.0 | 8.0 | 10.4 | 28.6 | 2.9 | |
| 693.7 | 3,493.8 | 921.9 | 95.8 | 9.0 | 8 | 35.1 | 2.8 | |
| 2,353.3 | 3,911.5 | 653.4 | 183.2 | 21.2 | 20.9 | 21.3 | 7.4 | |
| 225.5 | 4,863.0 | 6.7 | -160.8 | -2,578.1 | -106.2 | -- | 44.2 | |
| 580.7 | 4,099.7 | 2,028.9 | 150.6 | 7.5 | 6.2 | 29.8 | 1.7 |
No Review & Analysis are available.
--
Incorporated
2000
Chairman
--
Managing Director
Sandeep Bhardwaj
Headquarters
Indore, Madhya Pradesh
Website
Looking for more details about Zenith Drugs Ltd’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Zenith Drugs Ltd stood at ₹ 135 Cr as on 31-Mar-24
The share price of Zenith Drugs Ltd is ₹68.00 (NSE) as of 23-Jun-2025 12:14 IST. Zenith Drugs Ltd has given a return of 7.94% in the last 1 years.
Zenith Drugs Ltd has a market capitalisation of ₹ 117 Cr as on 20-Jun-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Zenith Drugs Ltd is 1.88 times as on 20-Jun-2025, a 48% discount to its peers’ median range of 3.61 times.
The P/E ratio of Zenith Drugs Ltd is 16.35 times as on 20-Jun-2025, a 58% discount to its peers’ median range of 39.17 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Zenith Drugs Ltd and enter the required number of quantities and click on buy to purchase the shares of Zenith Drugs Ltd.
The prominent promoters of Zenith Drugs Ltd are
| Name of promoters | Holding percentage |
|---|---|
|
AJAY SINGH DASSUNDI |
22.52%
|
|
SANDEEP BHARDWAJ |
21.38%
|
|
BHUPESH SONI |
20.18%
|
|
JAYWANTI SONI |
2.94%
|
|
PRIYANKA BHARADWAJ |
1.94%
|
The chairman of the company is , and the managing director is Sandeep Bhardwaj.
There is no promoter pledging in Zenith Drugs Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
12,264
|
|
|
4,949
|
|
|
4,130
|
|
|
4,026
|
|
|
3,944
|
|
|
3,505
|
|
|
3,498
|
|
|
3,370
|
|
|
2,624
|
| Zenith Drugs Ltd | Ratios |
|---|---|
|
Return on equity(%)
|
24.12
|
|
Operating margin(%)
|
11.54
|
|
Net Margin(%)
|
7.19
|
|
Dividend yield(%)
|
0
|
Yes, TTM profit after tax of Zenith Drugs Ltd was ₹10 Cr.
₹-0.30
(
